Mannucci E, Pala L, Ciani S, Bardini G, Pezzatini A, Sposato I, Cremasco F, Ognibene A, Rotella CM
Mounjaro ~22.5% average body weight loss Significant weight reduction Improves blood sugar levels Clinically proven weight loss Wegovy ~16.9% average body weight loss Boosts metabolic & cardiovascular health Proven, long-established safety profile Weekly injection, easy to use Key Takeaways: Retatrutide Benefits vs Risks Retatrutide shows promising potential, but its long-term safety and effectiveness are still being evaluated through clinical research
(7) N.Jelovac et al (1999) Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics: the effect on catalepsy and gastric ulcers in mice and rats European Journal of Pharmacology, 1999 Aug 20;379(1):19-31
! ,
10.1002/biof.5520260305 2 Al-KuraishyH
Advance to the next dose tier only after four consecutive weeks at the current dose with all four tolerability criteria met